PT  - JOURNAL ARTICLE
AU  - Schwendinger, F.
AU  - Wagner, J.
AU  - Knaier, R.
AU  - Infanger, D.
AU  - Rowlands, A.V.
AU  - Hinrichs, T.
AU  - Schmidt-Trucksäss, A.
TI  - Reference values for cut-point-free and traditional accelerometer metrics and associations with cardiorespiratory fitness: a cross-sectional study of healthy adults aged 20 to 89 years
AID  - 10.1101/2023.04.19.23288786
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.04.19.23288786
4099  - http://medrxiv.org/content/early/2023/04/25/2023.04.19.23288786.short
4100  - http://medrxiv.org/content/early/2023/04/25/2023.04.19.23288786.full
AB  - Objectives To compare the association between cardiorespiratory fitness (CRF) and cut-point-free accelerometer metrics (intensity gradient [IG] and average acceleration [AvAcc]) to that with traditional metrics in healthy adults aged 20 to 89 years and patients with heart failure, and 2) provide age-, sex-, and CRF-related reference values for healthy adults.Methods In the COmPLETE study, 463 healthy adults and 67 patients with heart failure wore GENEActiv accelerometers on their non-dominant wrist and underwent cardiopulmonary exercise testing. Cut-point-free (IG: distribution of intensity of activity across the day; AvAcc: proxy of volume of activity) and traditional (moderate-to-vigorous and vigorous activity) metrics were generated. The ‘rawacceleration’ application was developed to translate findings into clinical practice.Results IG and AvAcc yield complementary information on PA with both IG (p=0.009) and AvAcc (p<0.001) independently associated with CRF in healthy individuals. Only IG was independently associated with CRF in patients with heart failure (p=0.043). The best cut-point-free and cut-point-based model had similar predictive value for CRF in both cohorts. However, unlike traditional metrics, IG and AvAcc are comparable across populations and the most commonly used accelerometers. We produced age- and sex-specific reference values and percentile curves for IG, AvAcc, moderate-to-vigorous, and vigorous activity for healthy adults.Conclusions IG and AvAcc are strongly associated with CRF and, thus, indirectly with the risk of non-communicable diseases and mortality in healthy adults and patients with heart failure. Our reference values enhance the utility of cut-point-free metrics and facilitate their interpretation.Trial registration This study was registered on clinicaltrials.gov (NCT03986892).What is already known on this topic – Cut-point free accelerometer metrics are valuable to assess physical activity because of their comparability across populations and association with various health parameters (e.g. body fat content or physical functioning). Yet, their interpretation is not straightforward.What this study adds – This study found a strong and independent association of cut-point-free metrics with cardiorespiratory fitness, a vital sign, in healthy individuals aged between 20 to 89 years and patients with heart failure. We produced the first reference values based on healthy individuals across the age span.How this study might affect research, practice or policy – Our reference values together with the new open-source application may simplify the interpretation of cut-point-free accelerometer metrics and their use in clinical practice and research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe COmPLETE study was funded by the Swiss National Science Foundation (Grant no. 182815). AVR is supported by the Lifestyle Theme of the Leicester NHR Leicester Biomedical Research Centre and NIHR Applied Research Collaborations East Midlands (ARC-EM).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of North-western and Central Switzerland (EKNZ 2017-01451). All participants in this study provided informed written consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAvAccAverage accelerationCRFCardiorespiratory fitnessENMOEuclidean norm minus oneHEALTHYHealthy adultsHEARTPatients with heart failureIGIntensity gradientMVPAModerate-to-vigorous physical activityNT-proBNPN-terminal pro b-type natriuretic peptideNYHANew York Heart AssociationPAPhysical activitySDStandard deviationSEDSedentary timeTPATotal physical activityVO2peakPeak oxygen uptakeVPAVigorous physical activity